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Background: There are several risk factors for the colonisation, infection and spreading of antibiotic resistant
bacteria among elderly residents of nursing homes. An updated estimate of the native prevalence of antimicrobial
resistance in uropathogens among Swedish nursing home residents is needed.
Methods: Urine specimens were collected for culture and antimicrobial susceptibility testing against mecillinam,
ampicillin, cefadroxil, trimethoprim, nitrofurantoin and quinolones from the residents of 32 and 22 nursing homes,
respectively. The residents were capable of providing a voided urine sample in 2003 and 2012. In 2012 urine specimens
were also collected from residents with urinary catheters. Any antibiotic treatment during the previous month was
registered in 2003 as well as hospitalisation and any antibiotic treatment during the previous six months in 2012.
Results: The proportion of positive urine cultures was 32% (207/651) in voided urine specimens in 2003, 35% (147/421)
in 2012, and 46% (27/59) in urine samples from catheters in 2012. Escherichia coli (E. coli) was the most commonly
occurring bacteria.
Resistance rates in E. coli (voided urine specimens) in 2012 were; ampicillin 21%, trimethoprim 12%, mecillinam 7.7%,
ciprofloxacin 3.4%, cefadroxil 2.6% and nitrofurantoin 0.85%. There were no significant changes in the average
resistance rates in E. coli for antibiotics tested 2003–2012.
In 2012, two isolates of E. coli produced extended spectrum beta-lactamase enzymes (ESBL) and one with plasmid
mediated AmpC production.
Any antibiotic treatment during the previous month increased the risk for resistance in E. coli, adjusted for age and
gender; for mecillinam with an odds ratio (OR) of 7.1 (2.4-21; p = 0.00049), ampicillin OR 5.2 (2.4-11; p = 0.000036),
nalidixic acid OR 4.6 (1.4-16; p = 0.014) and trimethoprim OR 3.9 (1.6-9.2; p = 0.0023). Hospitalisation during the previous
six months increased the risk for antibiotic resistance in E. coli to ampicillin, ciprofloxacin and any antimicrobial tested,
adjusted for age, gender and antibiotic treatments during the previous six months.
Conclusions: The average rates of antimicrobial resistance were low and did not increase between 2003 and 2012 in
E. coli urinary isolates among Swedish nursing home residents. Antibiotic treatment during the previous month and
hospitalisation during the previous six months predicted higher resistance rates.
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Antimicrobial resistance is on the rise and a cause of major
concern in many countries [1]. Extensive antibiotic pre-
scription is related to a higher prevalence of antibiotic
resistant bacteria [2-7]. The elderly are prescribed antibiotics
more frequently than younger adults, and antibiotic courses
are common at nursing homes [8-14]. There are several
risk factors for colonisation, infection and spreading of
antibiotic resistant bacteria among elderly residents of
nursing homes such as catheters, decubitus ulcers and
other wounds [15,16].
There are some studies of antimicrobial resistance in
uropathogens among elderly residents at nursing homes,
however, there are considerable differences in resistance
rates between countries [17-22].
Antimicrobial resistance in urinary pathogens is still
favourable in Sweden within an international perspective
[23]. There was a low prevalence of ESBL-producing
bacteria in faecal samples collected in Swedish nursing
homes in 2008 [24]. However, between 2008 and 2010
ESBL faecal carriage increased both in the community
and at a university hospital in Sweden [25].
Resistance was generally low in 183 screening urine
samples from Swedish residents of nursing homes in
2008–2010 [26]. There was a tendency towards higher
antimicrobial resistance among strains isolated in 2010
from nursing home residents with indwelling bladder
catheters compared to all urine strains at that labora-
tory [27].
It is important to frequently update information con-
cerning the native prevalence of antimicrobial resistance
in uropathogens among residents of nursing homes, and
be on the alert for significant changes. Any changes might
affect empirical treatment of urinary tract infections (UTI)
and antibiotic stewardship in nursing homes.
The primary aim of this study was to describe anti-
microbial resistance rates in uropathogens among residents
of Swedish nursing homes in 2012 and compare these to
the rates from 2003.
The second aim of the study was to determine if anti-
biotic treatment within the previous month or hospita-
lisation within the previous six months predicted higher
resistance rates in uropathogens among residents of nursing
homes.
Methods
From January to March of 2003 and 2012, a single
voided urine specimen was collected from all included
residents of the participating nursing homes for the
elderly. In 2012, a single urine specimen was also col-
lected from residents with indwelling urinary catheters.
In 2003, the 32 participating nursing homes were lo-
cated in four municipalities in southwestern Sweden.
Two of these municipalities had 22 participating nursinghomes in 2012. The attending nurses were provided
detailed verbal and written information for the procedure.
The data from 2003 was collected as part of another
study evaluating dipstick urinalysis among elderly residents
of nursing homes [28] and evaluating the relationship
between nonspecific symptoms and bacteriuria [29].
Both parts of this study, the data gatherings in 2003 and
2012, were approved by the Regional ethical review board
of Gothenburg University (D-nr Ö 410–02 and 578–11).Inclusion and exclusion criteria
Residents of the participating nursing homes, regardless
of UTI symptoms were requested to participate. Those
accepting participation were included after having met
the following inclusion criteria:
 Permanent residence in nursing homes for the elderly
(regardless of gender)
 Presence at the nursing home during the study
 Participation approval
 No indwelling urinary catheter in 2003, only voided
urine specimens were collected
 Both voided urine specimens and specimens
from indwelling urinary catheters were collected
in 2012
 Sufficiently continent to leave a voided urinary
specimen (unless the resident had an indwelling
urinary catheter in 2012)
 Residents with dementia included if cooperative
when collecting urine samples
 No urostomy
 No regularly clean intermittent catheterisation
 No ongoing dialysis
 Not terminally ill
The following exclusion criterion was used:
 If the resident did not agree to participate or wished
to discontinue participationStatement of consent
Residents were informed of the study verbally and in
writing. Informed approval for participation in the study
was collected from decision-capable individuals choos-
ing to participate in the study. However, a considerable
number of participants consisted of residents with vary-
ing degrees of dementia. If incapable of understanding
the information and thereby possessing a reduced deci-
sion capability, these residents only participated so long
as they did not oppose participation, and under the con-
dition that appointed representative or relatives did not
oppose participation after having taken part of the study
information.
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In addition to collecting the urine sample, the attending
nurse made an entry in the study protocol, once for each
included resident, whether having ongoing or previous
antibiotic treatment within the last month or diabetes
mellitus. In 2012, the attending nurse also registered
overnight admissions to hospital, any antibiotic treatment
during the last six months, and an eventual diagnosis of
dementia.
Laboratory tests
The personnel at the nursing homes were instructed to
collect a mid-stream morning sample, or a voided urine
specimen with so long a bladder incubation time as
possible. Dipstick urinalysis was carried out at the nursing
home. The microbiology laboratory was provided informa-
tion on the outcome of the dipstick urinalysis as well as
information on any UTI symptoms from the attending
nurse. The urine specimens were cultured at the microbiol-
ogy laboratory in Borås according to clinical routine pro-
cedure. The urine samples were chilled before transport
and usually arrived at the laboratory within 24 hours.
The laboratory fractionated 10 μl urine on a cystine-
lactose-electrolyte deficient agar (CLED) and a Columbia
blood agar. Plates were incubated overnight (minimum
15 h) at 35–37°C. CLED plates were incubated in air and
Columbia plates were incubated in 5% CO2. The latter
was further incubated for 24 hours if no growth occurred
after the first incubation. Growth of bacteria was considered
significant if the number of colony-forming units (CFU)/mL
was ≥105. However, at signs of possible UTI such as a
positive nitrite dipstick, leukocyte esterase dipstick >1,
fever, frequency, urgency or dysuria, the cut-off point
was ≥103 for patients with a growth of Escherichia coli
(E. coli) and male patients with Klebsiella species (spp)
and Enterococcus faecalis (E. faecalis). For symptomatic
women harbouring the two latter species the cut-off level
was set at ≥104. At these lower cut-off points and with no
symptoms or signs of possible UTI, the urine cultures
were classified as sparse growth. For the purpose of this
study, both significant and sparse growth were defined as
a positive urine culture. In case of several detected species,
E. coli was selected in favour of secondary pathogens such
as Klebsiella spp. and in case of several E. coli, the most
prevalent isolate was selected. Growth of mixed flora was
classified as a negative urine culture.
The antimicrobial susceptibility of bacteria was deter-
mined according to the disk diffusion method described
by the Swedish Reference Group for Antibiotics (SRGA)
at the time. In 2012 antimicrobial susceptibility tests
followed guidelines and breakpoints proposed by the
European Committee on Antimicrobial Susceptibility Test-
ing (EUCAST) for the standardised disk diffusion test [30].
In 2003 nalidixic acid was used as a screening disk for anyquinolone resistance; in 2012 isolates were only tested for
ciprofloxacin resistance according to national guidelines.
Bacterial isolates with suspected extended spectrum
beta-lactamase (ESBL) production were confirmed as ESBL-
producing bacteria by the reference laboratory at the
Swedish Institute for Communicable Disease Control.
Statistical analysis
The population was described by number of individuals,
age and gender in 2003 and 2012. Any differences between
2003 and 2012 were compared either by Pearson chi-
square or T-test.
Differences between bacterial species and resistance pat-
terns between 2003 and 2012 were analysed by Pearson
chi-square, and when appropriate, Fisher’s exact test.
To evaluate the impact of previous antibiotic treatments
during the last month on antimicrobial resistance rates,
adjusted for age and gender, logistic regressions were
performed for those with E. coli in voided urine specimens
collected in 2003 and 2012. The outcome of antimicrobial
susceptibility testing was used as the dependent variable,
and any antibiotic treatment during the previous month,
age and gender as the independent variables. One re-
gression was made for each antibiotic commonly used
to treat UTI.
To evaluate the impact of hospitalisation during the
previous six months on antimicrobial resistance rates
adjusted for age, gender and any antibiotic treatment
during the previous six months, logistic regressions were
performed for those with E. coli in voided urine specimens
collected in 2012. The outcome of antimicrobial suscepti-
bility testing was used as the dependent variable, and any
hospitalisation and any antibiotic treatment during the
previous six months, as well as age and gender, as inde-
pendent variables. One regression was made for each
antibiotic commonly used to treat UTI and finally for
any antimicrobial resistance tested. Cramer’s V was calcu-
lated to evaluate any correlation between any hospitalisa-
tion and any antibiotic treatment during the previous six
months.
IBM SPSS Statistics version 21 was used for statistical
analysis.
Results
Studied population in 2003
In 2003, 751 of 1187 individuals in 32 nursing homes
fulfilled the inclusion criteria, and 655 (87%) accepted
participation (Figure 1). Voided urine samples were pro-
vided from 651 individuals, 482 (74%) women and 169
(26%) men. Women’s ages (mean 86 years, SD 7.4, range
46–102) were slightly higher than men’s (mean 82 years,
SD 7.8, range 54–99) (p < 10−6). 100/651 (15%) suffered
from diabetes mellitus. When the urine specimens were col-
lected, 26/651 (4.0%) were undergoing antibiotic treatment.
Elderly residents of 32 nursing homes 
n=1187
Not included (n=436)
Away when study took place n=8
Urine sample impossible to obtain 
due to severe incontinence or 
dementia n=291 
Urinary indwelling catheter n=96
Ongoing dialysis n=1 
Unknown reason n=40
Eligible patients fulfilling inclusion criteria n=751
Excluded patients (n=96)
Refused participation n=96
Conclusive results (n=651) Inconclusive results (n=4)
Data accidentally lost n=3
Two urine cultures were accidentally 
taken showing different results n=1
Figure 1 Participant flow chart 2003.
Sundvall et al. BMC Geriatrics 2014, 14:30 Page 4 of 10
http://www.biomedcentral.com/1471-2318/14/30Another 61/651 (9.4%) had no ongoing antibiotic treat-
ment when the urine specimens were collected, but
had received antibiotics during the previous month.
The antibiotic treatment history was, however, unknown
for 12/651 (1.8%). The presence of new or increased
urinary symptoms occurring during the previous week
was; for dysuria 5/651 (0.77%) and urinary urgency 6/651
(0.92%).Studied population in 2012
In 2012, 735 of 901 individuals in 22 nursing homes
fulfilled the inclusion criteria, with 484 (66%) accepting
participation (Figure 2). Urine samples were provided
from 480 individuals in 2012 (421 voided urine samples
and 59 urine samples from indwelling urinary catheters);
321 (67%) women and 159 (33%) men. Women’s ages
(87 years, SD 6.6, range 62–100) were slightly higher than
men’s (mean 85 years, SD 7.0, range 65–100) (p = 0.010).
71/480 (15%) suffered from diabetes mellitus, and 253/480
(53%) had dementia. When the urine specimens were
collected, 23/480 (4.8%) had ongoing antibiotic treatment.
Another 45/480 (9.4%) had no ongoing antibiotic treat-
ment when the urine specimens were collected, but had
received antibiotics during the previous month. The pres-
ence of new or increased urinary symptoms occurring
during the last week was for dysuria 5/480 (1.0%), urin-
ary urgency 6/480 (1.3%), and urinary frequency 2/480
(0.42%).Differences between the studied populations in 2003
and 2012
Men’s mean age was 3.1 years higher in 2012 compared to
2003 (p = 0.00016), while there was a statistically insig-
nificant trend towards a higher mean age among women
(0.92 year, p = 0.073). The proportion of men was higher
in 2012; 33% compared to 26% in 2003 (p = 0.0087).Bacterial findings
E. coli was by far the most common bacterial species.
Bacterial growths in urine cultures and distribution among
bacterial species are presented in Tables 1 and 2.
There was no significant difference in percentage of
positive urine cultures from voided urine samples in
2003 and 2012; 32% versus 35% (p = 0.29). However,
there was a significantly higher proportion of E. coli in
positive urine cultures from voided urine samples in
2012 compared to 2003; 117/147 (80%) versus 143/207
(69%), p = 0.027.
The proportion of positive urine cultures from voided
urine was more common among women than men;
184/482 (38%) versus 23/169 (14%), p < 10−6 in 2003 and
134/295 (45%) versus 13/126 (10%), p < 10−6 in 2012.
Findings of E. coli in positive urine cultures from
voided urine were more common among women than
men; 134/184 (73%) versus 9/23 (39%), p = 0.00098 in
2003 and 110/134 (82%) versus 7/13 (54%) p = 0.027 in
2012.
Elderly residents of 22 nursing homes
n=901
Not included (n=166)
Away when study took place n=6
Terminally ill n=15
Urine sample impossible to obtain due to  
substantial incontinence n=40
Urine sample impossible to obtain due to  
severe dementia n=55
Urine sample impossible to obtain due to  
severe incontinence/dementia n=14
Suprapubic catheter n=2
Clean intermittent catheterisation n=3
Urostomy n=1
For unknown reason not asked to 
participate n=30
Eligible patients fulfilling inclusion criteria n=735
Excluded patients (n=251)
Refused participation n=222
One ward withdrew during  
ongoing study n=27
Lack of time (attending nurse) 
n=2 
Conclusive results (n=480) Inconclusive results (n=4)
Urine for culture accidentally lost n=4
Figure 2 Participant flow chart 2012.
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The average resistance rates for all tested antibiotics
were similar between 2003 and 2012, however there was
a non-significant trend (p = 0.090) towards higher resist-
ance rates for cefadroxil in 2012, but still at the low level
of 2.6% for all E. coli isolates (Table 3). It was not pos-
sible to compare resistance rates for quinolones between
2003 and 2012 as nalidixic acid was no longer used as a
screening disk for quinolone resistance in 2012.
ESBL
In 2012, there were two isolates of E. coli producing
extended spectrum beta-lactamase (classic ESBL), and
one isolate with plasmid mediated AmpC production. No
carbapenemases were detected. No other ESBL-producing
Enterobacteriaceae were found.Table 1 Bacterial growths in urine cultures from 2003 and 20
Voided urine 2003 N = 651 Voide
Negative culture 68% (444)
Sparse growth 2.9% (19)
Significant growth 29% (188)
Sparse + significant growth 32% (207)
1There were mixed growths in all but one of cultures obtained from urinary catheteIn 2003, no ESBL-producing Enterobacteriaceae were
found.
Predictors of UTI antibiotic resistance in E. coli
Predictors for antibiotic resistance in voided urine speci-
mens are presented in Table 4.
In 2012 any overnight admission to hospital was reg-
istered. Cramer’s V between hospital admissions and
any antibiotic prescription was calculated, and there
was no correlation between “any hospitalisation during
the six last months” and “any antibiotic treatment during
the six last months”, 0.090 (p = 0.33). Of those in 2012
with E. coli in voided urine samples, 23/117 (20%) had
been hospitalised during the previous six months. To
evaluate the impact of this hospitalisation on antimicrobial
resistance rates, logistic regressions were performed, and12
d urine 2012 N = 421 Indwelling urinary catheter 2012 N = 59
65% (274) 54% (32)1
2.9% (12) 1.7% (1)
32% (135) 44% (26)
35% (147) 46% (27)
rs, classified as negative.
Table 2 Bacterial growth in positive urine cultures from voided urine at nursing homes for the elderly
========== 2003 ==========
Positive cultures
========== 2012 ==========
Positive cultures
Sparse
(n = 19)
Significant
(n = 188)
Total1
(n = 207)
Sparse
(n = 12)
Significant
(n = 135)
Total1
(n = 147)
Escherichia coli 6.8% (14) 62% (129) 69% (143) 5.4% (8) 74% (109) 80% (117)
Klebsiella species 0.48% (1) 11% (22) 11% (23) 0 7.5% (11) 7.5% (11)
Enterococcus faecalis 1.0% (2) 7.2% (15) 8.2% (17) 0 0.68% (1) 0.68% (1)
Enterococcus faecium 0.48% (1) 1.4% (3) 1.9% (4) 0 0 0
Proteus species 0 0 0 0 0.68% (1) 0.68% (1)
Proteus mirabilis 0 1.4% (3) 1.4% (3) 0 1.4% (2) 1.4% (2)
Proteus vulgaris 0 0.48% (1) 0.48% (1) 0 0.68% (1) 0.68% (1)
Enterobacter species 0 1.9% (4) 1.9% (4) 0 1.4% (2) 1.4% (2)
Psuedomonas aeruginosa 0 1.4% (3) 1.4% (3) 0 0 0
Citrobacter 0 0 0 0 1.4% (2) 1.4% (2)
Serratia liquefaciens 0 0 0 0 0.68% (1) 0.68% (1)
Staphylococcus aureus 0 0 0 0.68% (1) 0.68% (1) 1.4% (2)
Coagulase-negative staphylococci 0 1.9% (4) 1.9% (4) 0 0.68% (1) 0.68% (1)
Alpha-hemolytic streptococci 0 1.0% (2) 1.0% (2) 0 1.4% (2) 1.4% (2)
Group G beta-hemolytic streptococcus 0 0.48% (1) 0.48% (1) 1.4% (2) 0 1.4% (2)
Group C beta-hemolytic streptococcus 0 0 0 0.68% (1) 0 0.68% (1)
Group B beta-hemolytic streptococcus 0.48% (1) 0.48% (1) 1.0% (2) 0 0.68% (1) 0.68% (1)
1Growth of bacteria in all positive urine cultures, % (n).
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adjusted for age, gender and any antibiotic treatment
during the previous six months, was for ciprofloxacin
13 (1.1-153; p = 0.040), ampicillin 5.2 (1.8-15; p = 0.0021),
cefadroxil 8.6 (0.71-103; p = 0.091), trimethoprim 2.4 (0.70-
8.5; p = 0.16), mecillinam 2.1(0.48-9.5; p = 0.32), nitro-
furantoin 0.0 (0.0-∞; p = 1.0) and any antimicrobial tested
for 4.4 (1.6-12; p = 0.0033).Table 3 Resistance rates for UTI antibiotics in Escherichia
coli1, voided urine specimens
2003 (n = 143)2 2012 (n = 117)2 P-value3
Mecillinam 4.2% (6) 7.7% (9) 0.23
Ampicillin 18% (26) 21% (25) 0.52
Cefadroxil 0.0% (0) 2.6% (3) 0.090
Trimethoprim 13% (18) 12% (14) 0.88
Nitrofurantoin 0.70% (1) 0.85% (1) 1.0
Nalidixic acid 12% (17) Not tested —
Ciprofloxacin Not tested 3.4% (4) —
Classic ESBL4 1.7% (2)
AmpC5 0.85% (1)
1Sparse and significant growth of Escherichia coli.
2Proportion of resistant Escherichia coli % (number).
3Pearson chi-square and, when appropriate, Fisher’s exact test.
4E. coli producing extended spectrum beta-lactamase enzymes.
5E. coli with plasmid mediated AmpC production.Resistance rates in Klebsiella spp
The resistance rates among isolated Klebsiella spp. in
voided urine in 2003 were as follows; for ampicillin 96%
(22/23), nitrofurantoin 96% (22/23), mecillinam 13% (3/23),
nalidixic acid 9.0% (2/23), trimethoprim 0% (0/23) and
cefadroxil 0% (0/23).
The resistance rates among isolated Klebsiella spp. in
voided urine in 2012 were; for ampicillin 91% (10/11),
nitrofurantoin 91% (10/11), mecillinam 0% (0/11), cipro-
floxacin 0% (0/11), trimethoprim 27% (3/11) and cefadroxil
0% (0/11). Similar rates were seen in 10 Klebsiella isolates
from indwelling urinary catheters.
Urine specimens obtained from urinary catheters
In this study 46% (27/59) of the cultures of urine specimens
obtained from indwelling urinary catheters were classified
as positive. There were growths of mixed bacterial flora in
all but one of the cultures obtained from urinary catheters,
classified as negative. The bacterial findings in positive
urine cultures obtained from urinary catheters were;
E. coli 48% (13/27), Klebsiella spp. 37% (10/27), Proteus
mirabilis 11% (3/27) and Enterobacter spp. 3.7% (1/27).
Resistance rates in E. coli (catheter urine specimens)
in 2012 were; for ampicillin 46% (6/13), trimethoprim
15% (2/13), mecillinam 0% (0/13), ciprofloxacin 15%
(2/13), cefadroxil 7.7% (1/13) and nitrofurantoin 0% (0/13).
There was a trend towards higher resistance rates in
Table 4 Predictors of UTI antibiotic resistance in Escherichia coli1 in voided urine specimens
Unadjusted odds ratios (95% CI; p-value) Adjusted odds ratios (95% CI; p-value)
Mecillinam
Antibiotics last month2 7.2 (2.4-21; p = 0.00040) 7.1 (2.4-21; p = 0.00049)
Age 1.0 (0.94-1.1; p = 0.65) 1.0 (0.94-1.1; p = 0.62)
Gender3 <10−6 (0-∞; p = 1.0) <10−6 (0-∞; p = 1.0)
Ampicillin
Antibiotics last month2 5.2 (2.4-11; p = 0.000030) 5.2 (2.4-11; p = 0.000036)
Age 1.0 (0.98-1.1; p = 0.40) 1.0 (0.97-1.1; p = 0.42)
Gender3 0.26 (0.033-2.0; p = 0.20) 0.32 (0.040-2.6; p = 0.28)
Cefadroxil
Antibiotics last month2 <10−6 (0-∞; p = 1.0) <10−6 (0-∞; p = 1.0)
Age 1.1 (0.91-1.4; p = 0.28) 1.1 (0.91-1.4; p = 0.30)
Gender3 <10−6 (0-∞; p = 1.0) <10−6 (0-∞; p = 1.0)
Trimethoprim
Antibiotics last month2 4.0 (1.7-9.4; p = 0.0018) 3.9 (1.6-9.2; p = 0.0023)
Age 1.0 (0.96-1.1; p = 0.60) 1.0 (0.96-1.1; p = 0.65)
Gender3 <10−6 (0-∞; p = 1.0) <10−6 (0-∞; p = 1.0)
Nitrofurantoin
Antibiotics last month2 1.0×108 (0-∞; p = 1.0) 1.1×108 (0-∞; p = 0.99)
Age 1.2 (0.90-1.6; p = 0.22) 1.3 (0.88-1.8; p = 0.21)
Gender3 <10−6 (0-∞; p = 1.0) 1.2×10−5 (0-∞; p = 1.0)
Nalidixic acid4 2003
Antibiotics last month2 4.3 (1.4-13; p = 0.013) 4.6 (1.4-16; p = 0.014)
Age 0.92 (0.87-0.98; p = 0.014) 0.92 (0.86-0.99; p = 0.018)
Gender3 <10−6 (0-∞; p = 1.0) <10−6 (0-∞; p = 1.0)
Ciprofloxacin5 2012
Antibiotics last month2 3.1 (0.30-32; p = 0.35) 3.6 (0.32-40; p = 0.31)
Age 1.1 (0.91-1.3; p = 0.38) 1.1 (0.90-1.3; p = 0.36)
Gender3 <10−6 (0-∞; p = 1.0) <10−6 (0-∞; p = 1.0)
1N = 255 (22 sparse growth and 233 significant growth), voided urine specimens in 2003 and 2012 from patients with known antibiotic treatment history.
2Any ongoing (n = 8) or previous antibiotic treatment during the last month (n = 25). Reference category: no antibiotics last month.
3Reference category: female.
4Only includes residents from 2003 since nalidixic acid only was tested in 2003 (n = 138).
5Only includes residents from 2012 since ciprofloxacin only was tested in 2012 (n = 117).
Statistically significant findings are bold.
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voided urine for ampicillin (p = 0.079) and ciprofloxacin
(p = 0.11).
Discussion
Summary
There were still comparatively low levels of antimicro-
bial resistance in urinary pathogens among Swedish
nursing home residents with no major changes between
2003 and 2012. Any antibiotic treatment during the
last month and hospitalisation during the last six
months predicted higher resistance rates among urinary
pathogens.Strengths and limitations of the study
A major strength of this study is that urine samples were
collected from all those capable of providing a urine
sample at the participating nursing homes for the el-
derly. Thus, this study describes the native antimicro-
bial resistance in nursing homes for the elderly.
Previously, most studies of antimicrobial resistance in
uropathogens among elderly residents of nursing homes
compiled antimicrobial resistance in urine cultures
taken when the clinician suspected a UTI. Those with
UTI symptoms and underlying diseases in the urinary
tract comprised a selected patient group assumed to
have higher resistance rates.
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resistance rates at nursing homes in the same geographical
area between 2003 and 2012. Furthermore, since this
study includes many nursing homes they can be assumed
to be representative of all Swedish nursing homes, espe-
cially whereby nursing homes are similarly organised in all
regions of Sweden (municipal care).
In this study we obtained urine specimens and study
protocols from 55% (651/1187) of the individuals registered
at the nursing homes in 2003, and 53% (480/901) in 2012.
This may appear low but is similar to previously published
studies in nursing homes for the elderly [31]. One major
reason for not participating in this study was substantial
urinary incontinence, often combined with dementia. 8.1%
(96/1187) and 25% (222/901) of the individuals registered
at the nursing homes refused participation in 2003 and
2012, respectively. Still this may be considered acceptable
when studying an elderly fragile population with a high
proportion of residents with dementia as well as the
ethical requirement of approval from appointed repre-
sentatives/relatives.
Comparison with existing literature
Several studies have shown increased antimicrobial resist-
ance in uropathogens during the last ten years [2,32]. In
this study the average resistance rates for all tested antibi-
otics were similar between 2003 and 2012. In contrast to
most countries the prevalence of ESBL-producing Entero-
bacteriaceae was low in this study. This may be partly due
to successful efforts in Sweden to lower antibiotics usage
and the choice of narrow spectrum antibiotics in favour of
e.g. ciprofloxacin [23,33].
The overall resistance rates in E. coli for UTI antibiotics
in Sweden in 2012 [23] as compared to this study (% R in
Sweden/% R in this study) were; for ampicillin 31%/
21%, mecillinam 4.6%/7.7%, cefadroxil 3.5%/2.6%, nitro-
furantoin 1.1%/0.85%, trimethoprim 19%/12% and cipro-
floxacin 7.6%/3.4%. Thus, the proportion of resistant
bacteria was lower than expected for all antibiotics ex-
cepting mecillinam in this study. This might be partly
explained by national statistics being based on clinical
isolates and our material from all those able to provide a
urine specimen. On the other hand a nursing home popu-
lation can be assumed to have higher antimicrobial resis-
tance rates since they have a high level of co-morbidity
and are prescribed more antibiotics than younger indivi-
duals. Thus, it is satisfying to note that a Swedish nursing
home population still has comparatively low antimicrobial
resistance rates among E. coli.
Hospitalisation during the previous six months increased
the risk for antibiotic resistance in E. coli against ampicillin,
ciprofloxacin and any antimicrobial tested, adjusted for age,
gender and any antibiotic treatment during the previous six
months. This is consistent with several articles reportingprior hospitalisation as a risk factor for antimicrobial re-
sistance which suggests that the hospital is a source of
antibiotic-resistant organisms [15].
There was a low prevalence of new or increased dysuria
and urgency in this study compared to studies collecting
urine specimens from patients with suspected UTI. This
was expected as it was a screening study collecting urine
specimens from all those able to provide a urine sample
at the participating nursing homes, regardless of the
presence of symptoms.
Methodological aspects
Procedures utilizing the presence of symptoms or outcomes
of prior dipstick testing, to influence the setting of cut-off
levels for CFU/mL in urine cultures to label growth as
clinically significant, may enhance the diagnostic proced-
ure [34]. This procedure has also been used in previous
studies of antimicrobial susceptibility whereby it reflects
the clinical situation [6,32,35]. Few individuals had any
specific symptom of UTI, but many had significant
growth, which is an important result to consider when
evaluating urine samples in this population. In this
study, when analysing antibiotic susceptibility all iso-
lates with sparse or significant growth were included to
identify the pool of resistant bacteria in the nursing
home population.
In general, there are some minor differences in break-
points between 2003 and 2012 due to methodological
changes over time. In case of a difference, the break-
points have only been changed so that a bacterium is
more likely to be classified as resistant in 2012 as compared
to 2003. For the quinolones, nalidixic acid was no longer
used as a screening disk in 2012. Thus, it is not possible to
properly compare resistance rates for quinolones during
the studied period.
It is inappropriate to compare resistance rates for
Klebsiella isolates between 2003 and 2012 due to the low
numbers of Klebsiella spp. in 2012.
E. coli was by far the most common finding among all
isolated species both in 2003 and 2012. However, the
proportion of E. coli in voided urine was higher in 2012;
80% (117/147) as compared to 69% (143/207) in 2003.
This could in part depend on the lower proportion of
E. faecalis in 2012; 0.68% (1/147) versus 8.2% (17/207)
in 2003. Even if these are small numerical differences,
we cannot provide any satisfactory explanation. We
have no data indicating more complicating factors
within the urinary tract in 2003, since we have not in-
vestigated for that.
Urine culture screening for bacteriuria was used in this
study to describe native antimicrobial resistance, however,
in clinical practice urine specimens should not be
considered unless patients have symptoms from the
urinary tract.
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There were still comparatively low levels of antimicrobial
resistance for urinary pathogens among Swedish nursing
home residents with no major changes between 2003 and
2012. Any antibiotic courses during the previous month
and hospitalisation during the previous six months pre-
dicted higher resistance rates among urinary pathogens
in this study. It is important to use antibiotics properly
and continue analysing antimicrobial resistance in nurs-
ing homes to guide empirical treatment due to the po-
tentially high risk for increasing antibiotic resistance in
this population.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All authors participated in the design of the study. PDS and ME collected the
data. PDS analysed the data and drafted the manuscript. All authors
contributed to the interpretation of the analyses, critical reviews and
revisions, and final approval of the paper.
Acknowledgements
We are grateful to the laboratory staff of the Bio Imaging and Laboratory
Medicine Unit, Södra Älvsborg Hospital and to all the nursing home staff
members who assisted in this study. Thanks to associate professor Christina
Åhrén for critically reading the manuscript.
Financial support was obtained from primary health care in Södra Älvsborg
County, the Research and Development Council of the Södra Älvsborg
County and FoU Sjuhärad Välfärd (a research and development unit in
Borås). Sponsors took no part in the design, methods, subject recruitment,
data collection, analysis or preparation of manuscript.
Author details
1Research and Development Unit, Primary Health Care in Southern Älvsborg
County, Sven Eriksonsplatsen 4, SE-503 38, Borås, Sweden. 2Department of
Public Health and Community Medicine, Institute of Medicine, the
Sahlgrenska Academy, University of Gothenburg, Box 100, SE-405 30
Gothenburg, Sweden. 3Sandared Primary Health Care Centre, Sandared,
Sweden. 4Health Care Unit, Borås Municipality, Våglängdsgatan 21 B, SE-507
41 Borås, Sweden. 5Cairns Clinical School, School of Medicine and Dentistry,
James Cook University, Cairns Base Hospital, PO Box 902, Cairns, QLD 4870,
Australia. 6Department of Clinical Sciences, General Practice, Lund University,
CRC, Hus 28, Plan 11, Jan Waldenströms gata 35, SE-205 02 Malmö, Sweden.
7Centre for Clinical Research, Dalarna, Sweden and Falu Vårdcentral, Södra
Mariegatan 18, SE-791 70 Falun, Sweden. 8Department of Public Health and
Caring Sciences, Family Medicine, Uppsala University, Uppsala, Sweden. 9Bio
Imaging and Laboratory Medicine Unit, Södra Älvsborg Hospital, SE-501 82
Borås, Sweden. 10Department of Infectious Diseases, Institute of Biomedicine,
the Sahlgrenska Academy, University of Gothenburg, Sweden and
Department of Communicable Disease Control, Västra Götalandsregionen
SE-501 82 Borås, Sweden.
Received: 23 October 2013 Accepted: 6 March 2014
Published: 13 March 2014
References
1. WHO: The evolving threat of antimicrobial resistance - Options for action.
Geneva: World Health Organization; 2012.
2. Blaettler L, Mertz D, Frei R, Elzi L, Widmer AF, Battegay M, Fluckiger U:
Secular trend and risk factors for antimicrobial resistance in escherichia
coli isolates in Switzerland 1997–2007. Infection 2009, 37(6):534–539.
3. Cohen AE, Lautenbach E, Morales KH, Linkin DR: Fluoroquinolone-resistant
escherichia coli in the long-term care setting. Am J Med 2006,
119(11):958–963.
4. Cohen-Nahum K, Saidel-Odes L, Riesenberg K, Schlaeffer F, Borer A: Urinary
tract infections caused by multi-drug resistant Proteus mirabilis: risk
factors and clinical outcomes. Infection 2010, 38(1):41–46.5. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD: Effect of antibiotic
prescribing in primary care on antimicrobial resistance in individual
patients: systematic review and meta-analysis. BMJ 2010, 340:c2096.
6. Smithson A, Chico C, Ramos J, Netto C, Sanchez M, Ruiz J, Porron R, Bastida
MT: Prevalence and risk factors for quinolone resistance among
escherichia coli strains isolated from males with community febrile
urinary tract infection. Eur J Clin Microbiol Infect Dis 2012, 31(4):423–430.
7. Vellinga A, Murphy AW, Hanahoe B, Bennett K, Cormican M: A multilevel
analysis of trimethoprim and ciprofloxacin prescribing and resistance of
uropathogenic escherichia coli in general practice. J Antimicrob
Chemother 2010, 65(7):1514–1520.
8. Blix HS, Bergman J, Schjott J: How are Antibacterials used in nursing homes?
results from a point-prevalence prescription study in 44 Norwegian nursing
homes. Pharmacoepidemiol Drug Saf 2010, 19(10):1025–1030.
9. Daneman N, Gruneir A, Newman A, Fischer HD, Bronskill SE, Rochon PA,
Anderson GM, Bell CM: Antibiotic use in long-term care facilities.
J Antimicrob Chemother 2011, 66(12):2856–2863.
10. Fagan M, Maehlen M, Lindbaek M, Berild D: Antibiotic prescribing in
nursing homes in an area with low prevalence of antibiotic resistance:
compliance with national guidelines. Scand J Prim Health Care 2012,
30(1):10–15.
11. Latour K, Catry B, Broex E, Vankerckhoven V, Muller A, Stroobants R,
Goossens H, Jans B: Indications for antimicrobial prescribing in European
nursing homes: results from a point prevalence survey.
Pharmacoepidemiol Drug Saf 2012, 21(9):937–944.
12. McClean P, Hughes C, Tunney M, Goossens H, Jans B: Antimicrobial prescribing
in European nursing homes. J Antimicrob Chemother 2011, 66(7):1609–1616.
13. Pettersson E, Vernby A, Molstad S, Lundborg CS: Infections and antibiotic
prescribing in Swedish nursing homes: a cross-sectional study. Scand J
Infect Dis 2008, 40(5):393–398.
14. Rummukainen ML, Karki T, Kanerva M, Haapasaari M, Ollgren J, Lyytikainen
O: Antimicrobial prescribing in nursing homes in Finland: results of three
point prevalence surveys. Infection 2013, 41(2):355–360.
15. van Buul LW, van der Steen JT, Veenhuizen RB, Achterberg WP, Schellevis
FG, Essink RT, van Benthem BH, Natsch S, Hertogh CM: Antibiotic use and
resistance in long term care facilities. J Am Med Dir Assoc 2012,
13(6):568. e561-513.
16. Strausbaugh LJ, Crossley KB, Nurse BA, Thrupp LD: Antimicrobial resistance in
long-term-care facilities. Infect Control Hosp Epidemiol 1996, 17(2):129–140.
17. Benenson S, Cohen MJ, Block C, Stern S, Weiss Y, Moses AE: Vancomycin-
resistant enterococci in long-term care facilities. Infect Control Hosp
Epidemiol 2009, 30(8):786–789.
18. Das R, Perrelli E, Towle V, Van Ness PH, Juthani-Mehta M: Antimicrobial
susceptibility of bacteria isolated from urine samples obtained from nursing
home residents. Infect Control Hosp Epidemiol 2009, 30(11):1116–1119.
19. Friedmann R, Hamburger R, Shulman C, Yinnon AM, Raveh D: Antimicrobial
susceptibilities of urinary pathogens in a multidisciplinary long-term care
facility. Diagn Microbiol Infect Dis 2003, 46(3):217–222.
20. Loeb MB, Craven S, McGeer AJ, Simor AE, Bradley SF, Low DE, Armstrong-Evans
M, Moss LA, Walter SD: Risk factors for resistance to antimicrobial agents
among nursing home residents. Am J Epidemiol 2003, 157(1):40–47.
21. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein
RA: Multiple antibiotic-resistant klebsiella and escherichia coli in nursing
homes. JAMA 1999, 281(6):517–523.
22. Xie C, Taylor DM, Howden BP, Charles PG: Comparison of the
bacterial isolates and antibiotic resistance patterns of elderly
nursing home and general community patients. Intern Med J 2012,
42(7):e157–e164.
23. Hellman J, Olsson-Liljequist B, Bengtsson B, Greko C (Eds): SWEDRES-SVARM
2012. Use of antimicrobials and occurrence of antimicrobial resistance in
Sweden. Solna/Uppsala: Swedish Institute for Communicable Disease Control
and National Veterinary Institute; 2013.
24. Andersson H, Lindholm C, Iversen A, Giske CG, Ortqvist A, Kalin M, Fossum
B: Prevalence of antibiotic-resistant bacteria in residents of nursing
homes in a Swedish municipality: healthcare staff knowledge of and
adherence to principles of basic infection prevention. Scand J Infect Dis
2012, 44(9):641–649.
25. Stromdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I:
Prevalence of faecal ESBL carriage in the community and in a hospital
setting in a county of Southern Sweden. Eur J Clin Microbiol Infect Dis
2011, 30(10):1159–1162.
Sundvall et al. BMC Geriatrics 2014, 14:30 Page 10 of 10
http://www.biomedcentral.com/1471-2318/14/3026. Olofsson M, Toepfer M, Ostgren CJ, Midlov P, Matussek A, Lindgren PE,
Molstad S: Low level of antimicrobial resistance in escherichia coli
among swedish nursing home residents. Scand J Infect Dis 2013,
45(2):117–123.
27. Jonsson K, Claesson BE, Hedelin H: Urine cultures from indwelling bladder
catheters in nursing home patients: a point prevalence study in a
Swedish county. Scand J Urol Nephrol 2011, 45(4):265–269.
28. Sundvall PD, Gunnarsson RK: Evaluation of dipstick analysis among elderly
residents to detect bacteriuria: a cross-sectional study in 32 nursing
homes. BMC Geriatr 2009, 9:32.
29. Sundvall PD, Ulleryd P, Gunnarsson RK: Urine culture doubtful in
determining etiology of diffuse symptoms among elderly individuals:
a cross-sectional study of 32 nursing homes. BMC Fam Pract 2011, 12:36.
30. The European Committee on Antimicrobial Susceptibility Testing – EUCAST.
[www.eucast.org]
31. Hedin K, Petersson C, Wideback K, Kahlmeter G, Molstad S: Asymptomatic
bacteriuria in a population of elderly in municipal institutional care.
Scand J Prim Health Care 2002, 20(3):166–168.
32. Kahlmeter G, Poulsen HO: Antimicrobial susceptibility of escherichia coli
from community-acquired urinary tract infections in Europe: the ECO.
SENS study revisited. Int J Antimicrob Agents 2012, 39(1):45–51.
33. Molstad S, Cars O, Struwe J: Strama–a Swedish working model for
containment of antibiotic resistance. Euro Surveill 2008, 13(46):19041.
34. Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK: Diagnosis
of coliform infection in acutely dysuric women. N Engl J Med 1982,
307(8):463–468.
35. Kahlmeter G: An international survey of the antimicrobial susceptibility of
pathogens from uncomplicated urinary tract infections: the ECO.SENS
Project. J Antimicrob Chemother 2003, 51(1):69–76.
doi:10.1186/1471-2318-14-30
Cite this article as: Sundvall et al.: Antimicrobial resistance in urinary
pathogens among Swedish nursing home residents remains low: a
cross-sectional study comparing antimicrobial resistance from 2003 to
2012. BMC Geriatrics 2014 14:30.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
